000			02019nam a2200409Ia 4500
001			289246
003			OCoLC
005			20160527201943.0
008			020416s2001 caua b 001 0 eng d
010			_a 2002280211
015			_aGBA2-02460
016	7		_a101119701 _2DNLM
020			_a0120176459
020			_a9780120176458
035			_a(OCoLC)46848769
040			_aZRS _cDLC _dZRS _dCOU _dAGL _dUKM _dNLM _dBAKER _dBTCTA _dOCLCG
042			_alccopycat
049			_aPUXA
050	0	0	_aRC632.N47 _bB38 2001
060	0	0	_aW1 _bAD615 v.45 2001
060	1	0	_aWD 205.5.L5 _bB335 2001
070	0		_a443 _bD39 v. 45
072		0	_aX300
082	0	0	_a616.8/3 _221
092	0		_a575.1 _bA244
245	0	0	_aBatten disease _bdiagnosis, treatment, and research _cedited by Krystyna E. Wisniewski, Nanbert Zhong.
260			_aSan Diego _bAcademic Press _cc2001.
300			_axiii, 243 p. _bill. _c24 cm.
490		0	_aAdvances in genetics _vv. 45 _2Local _949476
504			_aIncludes bibliographical references and index.
505	0		_aNeuronal ceroid lipofuscinoses: classification and diagnosis -- Cellular pathology and pathogenic aspects of neuronal ceroid lipofuscinoses -- Positional candidate gene cloning of CLN1 -- Biochemistry of neuronal ceroid lipofuscinoses -- Positional cloning of the JNCL gene, CLN3 -- Studies of homogenous populations: CLN5 and CLN8 -- Molecular genetic testing for neuronal ceroid lipofuscinoses -- Genetic counseling in the neuronal ceroid lipofuscinoses -- Neurotrophic factors as potential therapeutic agents in neuronal ceroid lipofuscinosis -- Animal models for the ceroid lipofuscinoses -- Experimental models of NCL: the yeast model -- Outlook for future treatment.
650		0	_aNeuronal ceroid-lipofuscinosis. _2Local _9142250
650	2	2	_aNeuronal Ceroid-Lipofuscinoses _xgenetics. _2Local _9142249
650	1	2	_aNeuronal Ceroid-Lipofuscinoses _2Local _9142249
700	1		_aWisniewski, K. E. _q(Krystyna E.) _2Local _9189901
700	1		_aZhong, Nanbert. _2Local _9192003
999			_c209335 _d209335